Takeda scraps late-stage amyloidosis study

70

Takeda Pharmaceutical Co Ltd said on Wednesday it would discontinue a late-stage study testing its experimental treatment for amyloidosis, as it did not meet the first of two main goals.

http://feeds.reuters.com/~r/reuters/healthNews/~3/LA8x6UJz_5Q/takeda-scraps-late-stage-amyloidosis-study-idUSKCN1T62P5